EverCommerce enters the post-earnings period with a notable shift in the lending market — availability has risen to 7.1%, the highest reading in over a month — yet the underlying structure of this trade remains as hostile to shorts as it has been all summer.
The most important data point this week is what has changed and, equally, what hasn't. Availability has climbed from the 0.71% floor hit on August 4 — where roughly one share remained lendable for every 140 already out on loan — to 7.1% today. That is a genuine loosening. It follows a brief moment on August 4 when the lending pool was completely exhausted at 100% utilisation. Cost to borrow has also eased, falling to 46.2% annualised from a weekly high above 60%, down roughly 9% on the week. Short interest has drifted lower too, trimming 4.2% over seven days to sit at approximately 1% of free float. The direction of travel is toward less pressure. But the absolute level remains extreme: 46% annualised borrow costs and single-digit availability are not normal. Correlated peers ALRM and VERX borrow at well under 1%. The ORTEX short score is 95.1, essentially flat across every session of the past two weeks. The structural idiosyncrasy has not resolved — it has merely pulled back from its most acute readings.
The Street's reaction to Q2 results tells a similarly mixed story. RBC Capital's Matthew Hedberg trimmed his target to $10 from $11 on August 6 while holding a Sector Perform rating — a modest downgrade in conviction that followed the print. Barclays moved in the opposite direction, raising its target from $8.50 to $10 while keeping an Underweight rating, acknowledging the stock's resilience without changing the bearish call. The result is a consensus that is neither clearly upgrading nor abandoning the name. The mean analyst price target of $11 sits close to the current $10.92 price, leaving almost no implied upside on the Street's central case. Goldman Sachs retains a Sell rating with an $8 target, set back in March — that gap with the current price is material and the target has not been updated post-earnings. The bull case rests on 6.8% payments revenue growth and a 29% year-over-year increase in customers using multiple solutions. Bears point to concentration risk: a small subset of high-revenue customers drives a disproportionate share of the business, and any churn there hits hard.
Insider activity adds the sharpest colour to the fundamental debate. The CEO and founder Eric Remer has sold shares on at least seven separate occasions since mid-July, including two sales in the first week of August at prices between $11.84 and $12.13 — all while the stock was trading well above where it ended the week at $10.92. The President, Matthew Feierstein, sold 30,000 shares across three consecutive sessions in early August. Net insider selling over the past 90 days totals approximately $2.9 million. These are modest in absolute dollar terms relative to the founders' stakes, and the trade significance scores are low, suggesting scheduled or routine disposals rather than urgent liquidation. But the timing — sustained selling into a 20%-plus one-month rally — is a pattern worth noting alongside the analyst caution.
The stock itself fell 11.4% on August 5 following the earnings release, then recovered 2.9% on August 7 to close the week at $10.92, leaving it down 11.5% over seven days but still up 8.4% over the past month. Options positioning is heavily skewed toward puts: the put/call ratio runs at 4.36, modestly above its 20-day average of 4.08 and around 1.3 standard deviations elevated. The ratio has been structurally high all year — the 52-week low is 0.02 — suggesting the options market on this name is dominated by hedgers rather than directional speculators. The post-earnings dip briefly brought peer IIIV down a sharp 17% on the week, while SPT surged 20% — the software cohort is trading on idiosyncratic prints right now, not a single macro tape.
The next earnings event is scheduled for November 6. Between now and then, the question is whether the modest loosening in the borrow market continues — and whether the ORTEX short score, which has held above 95 without interruption for weeks, finally shows any meaningful decline.
See the live data behind this article on ORTEX.
Open EVCM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
